Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/02/2010WO2010136536A1 Anti-ck8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
12/02/2010WO2010136508A2 Stem cell targeting
12/02/2010WO2010136480A1 Antigen-binding proteins
12/02/2010WO2010136212A1 Lipoxygenase and its use in wound healing
12/02/2010WO2010135915A1 Use of midkine and medical device containing midkine
12/02/2010WO2010135854A1 Use of rlz-8 for the prevention or treatment of thrombocytopenia and a pharmaceutical composition comprising rlz-8
12/02/2010WO2010098788A3 Pd-i antagonists and methods for treating infectious disease
12/02/2010WO2010095978A3 Method for preparing a proinsulin preparation for peroral use
12/02/2010WO2010085588A3 Modulating angiogenesis
12/02/2010WO2010080124A9 Nkg2d-fc for immunotherapy
12/02/2010WO2010062756A3 Preventing and treating sepsis
12/02/2010WO2010049438A3 Improved methods of using phosphoantigens for the treatment of diseases
12/02/2010WO2010021879A3 Use of ultrarapid acting insulin
12/02/2010US20100305547 Method of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
12/02/2010US20100305500 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010US20100305308 Lactoferrin
12/02/2010US20100305307 Human monoclonal antibodies to epidermal growth factor receptor
12/02/2010US20100305306 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/02/2010US20100305199 Therapeutic regimen for treating cancer
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305151 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
12/02/2010US20100305051 Natriuretic activities
12/02/2010US20100305050 Protein product with modified antigenicity
12/02/2010US20100305049 Novel Wheat Allergens
12/02/2010US20100305048 Novel use of cytokine inhibitors
12/02/2010US20100305047 Cyclosporin derivatives for enhancing the growth of hair
12/02/2010US20100305046 Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
12/02/2010US20100305045 Omega-3 oil containing ophthalmic emulsions
12/02/2010US20100305044 Peptide anti-tumor agent
12/02/2010US20100305043 Ccl18 and ccl3 methods and compositions for detecting and treating cancer
12/02/2010US20100305042 Pharmaceutical compositions and methods for the treatment of prostate cancer
12/02/2010US20100305041 Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same
12/02/2010US20100305040 Production of soluble recombinant protein by pi value control of n-terminal
12/02/2010US20100305039 Production of collagen in the milk of transgenic mammals
12/02/2010US20100305038 Diagnostic of immune graft tolerance using tmtc3 gene expression levels
12/02/2010US20100305037 Cyclosporin derivatives for treating inflammatory diseases and conditions
12/02/2010US20100305036 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders
12/02/2010US20100305035 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305032 Novel GLP-1 Derivatives
12/02/2010US20100305031 Peptide having an extending action for half-life of object peptide in plasma
12/02/2010US20100305030 Nanoparticles of therapeutic agents having low water solubility
12/02/2010US20100305029 Paralytic Peptide for Use in Neuromuscular Therapy
12/02/2010US20100305028 Cholesterol derivatives of inhibitors of viral fusion
12/02/2010US20100305027 Cyclic peptides comprising at least one aza-b3-aminoacyl residue and their uses
12/02/2010US20100305026 CD44V6 peptides as inhibitors of bacterial infections
12/02/2010US20100305025 Rnase a peptides, fragments and uses thereof
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100305023 Method of Delaying The Onset of Clinically Definite Multiple Sclerosis
12/02/2010US20100305022 Low molecular weight heparin composition and uses thereof
12/02/2010US20100304401 Ys68 gene involved in primitive hematopoiesis
12/02/2010US20100303929 Compounds and methods for treating cancer
12/02/2010US20100303928 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions
12/02/2010US20100303923 Endotoxin adsorbent for the prevention and treatment of autoimmune diseases
12/02/2010US20100303915 Therapeutic opthalmic emulsions
12/02/2010US20100303912 Nanocell Drug Delivery System
12/02/2010US20100303901 Oral delivery of proteins and peptides
12/02/2010US20100303898 Collagen dispersion and method of producing same
12/02/2010US20100303897 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
12/02/2010US20100303893 Novel compound for treatment of tumor
12/02/2010US20100303889 Compositions and Methods for Promoting Patency of Vascular Grafts
12/02/2010US20100303888 Composition for enhancing bone formation
12/02/2010US20100303887 DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells
12/02/2010US20100303886 Graft materials and methods for staged delivery of bioactive components
12/02/2010US20100303884 Growth factor complexes and modulation of cell migration and growth
12/02/2010US20100303881 Therapeutic Electrospun Fiber Compositions
12/02/2010US20100303878 Biodegradable bioactive agent releasing matrices with particulates
12/02/2010US20100303832 Genes and polymorphisms associated with amd
12/02/2010US20100303824 Signaling intermediates in an in vitro model of alzheimer's disease
12/02/2010US20100303822 Polypeptides from non-typeable haemophilus influenzae
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303819 Dcl-1 and uses thereof
12/02/2010US20100303818 Dendritic cell receptor
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
12/02/2010US20100303814 Antibodies Against a Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
12/02/2010US20100303813 Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
12/02/2010US20100303804 Composition that can be cured by polymerisation for the production of biodegradable, biocompatible, cross-linkable polymers on the basis of polyvinyl alcohol
12/02/2010US20100303803 Catenate for immunostimulation
12/02/2010US20100303800 Methods and compositions for treating ischemia
12/02/2010US20100303799 Treatment of Conditions Related to Shock
12/02/2010US20100303798 Methods of Treating Urogenital-Neurological Disorders Using Neurotrophin Retargeted Endopepidases
12/02/2010US20100303797 Use of p97 As An Enzyme Delivery System For The Delivery of Therapeutic Lysosomal Enzymes
12/02/2010US20100303796 Method for Treating Systemic DNA Mutation Disease
12/02/2010US20100303795 Marker of prostate cancer
12/02/2010US20100303794 Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases
12/02/2010US20100303793 Combination therapy for cardiac revascularization and cardiac repair
12/02/2010US20100303792 Protein synthesis required for long-term memory is induced by pkc activation on days preceding associative learning
12/02/2010US20100303791 Methods of Treating Chronic Neurogenic Inflammation Using Glucagon Like Hormone Retargeted Endopepidases
12/02/2010US20100303790 Use of biliverdin reductase (bvr) and bvr peptide fragments to treat coronary disorders
12/02/2010US20100303789 Methods of Treating Chronic Neurogenic Inflammation Using Neurotrophin Retargeted Endopepidases
12/02/2010US20100303788 Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases
12/02/2010US20100303787 Methods of Treating Urogenital-Neurological Disorders Using Galanin Retargeted Endopepidases
12/02/2010US20100303786 Stabilisation of Liquid-Formulated Factor VII(A) Polypeptides by Aldehyde-Containing Compounds
12/02/2010US20100303785 Novel therapeutics based on tau/microtubule dynamics
12/02/2010US20100303783 Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases
12/02/2010US20100303781 Treatment
12/02/2010US20100303773 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activity and use thereof
12/02/2010US20100303769 Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
12/02/2010US20100303761 Lipidized Interferon and Uses Thereof
1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 3163